Severe bullous pemphigoid following Covid‐19 vaccination resistant to rituximab and successfully treated with dupilumab

Maria Efenesia Baffa, Roberto Maglie, Francesca Montefusco, Carlo Pipitò, Stefano Senatore, Emiliano Antiga

2022Journal of the European Academy of Dermatology and Venereology16 citationsDOI

Abstract

Report of a case of bullous pemphigoid induced by SARS-CoV2 vaccination successfully treated with dupilumab (after unsuccessfull treatment with steroids and rituximab)

Topics & Concepts

MedicineSection (typography)Coronavirus disease 2019 (COVID-19)DermatologyLibrary sciencePathologyDiseaseBusinessInfectious disease (medical specialty)AdvertisingComputer scienceAutoimmune Bullous Skin DiseasesUrticaria and Related ConditionsCoagulation, Bradykinin, Polyphosphates, and Angioedema